Charles River Laboratories International, Inc. CRL

Company Overview

Charles River Laboratories International, Inc. is a global contract research organization (CRO) that provides essential products and services to support the discovery, development, and manufacturing of new drugs, biologics, and medical devices. The company operates primarily within the biopharmaceutical, biotechnology, medical device, and academic research industries, serving clients across the entire research and development lifecycle from early discovery through preclinical and clinical support.

The company’s primary revenue drivers include research models and services, preclinical drug discovery and safety assessment services, and manufacturing support solutions for advanced therapies. Charles River is positioned as a critical outsourcing partner for pharmaceutical and biotechnology companies, offering integrated capabilities that reduce development timelines and regulatory risk. Founded in 1947 as a laboratory animal supplier, the company has evolved through organic growth and acquisitions into a diversified global CRO with a strong emphasis on scientific expertise, regulatory compliance, and scale.